Study: Ritalin treats apathy in patients with Alzheimer's disease
Leslye Nathe did not realize the profound effect that Ritalin was having on her mother's Alzheimer's disease until a doctor stopped the prescription.
Her mother, Susan Brown, 74, a resident at Provision Living in Webster Groves, Mo., began sleeping nearly all the time. And during rare moments, when she was awake, she was tearing the sheets off of her bed and scratching wounds into her arms.
"She was like a child having a tantrum and she kept telling people to leave. She was very paranoid," Nathe said. "She would beg me, 'Please, please get me some medication. There's something wrong. I can't deal with it anymore.'"
Brown had been taking Ritalin for many years even before she was diagnosed with Alzheimer's, to treat attention deficit disorder and depression.
Her reaction to being taken off the drug was more extreme than usual, but it supported the long-held notion that Ritalin is key to controlling some Alzheimer's symptoms.
Grossberg and a team of researchers at the university, recently received a $183,540 grant from Noven Pharmaceuticals Inc. to study Ritalin as a therapy for apathy and fall risk in Alzheimer's patients. Both are common symptoms of Alzheimer's disease, affecting about 70 percent patients who have it.
Noven is a joint-venture partner of Novartis Pharmaceuticals, which manufactures Ritalin. Novartis paid Grossberg $28,000 in 2010 to speak about its products to other physicians.
Grossberg said family members frequently notice that loved ones are indifferent, socially disengaged and have lost all enthusiasm.
"It's serious couch-potatoism, and it drive relatives crazy," Grossberg said. "There's a lot of evidence that Ritalin has mood-elevating effects and also makes them more aware of their environment and obstacles. They also make better decisions."
Scientists are not sure what causes apathy in patients with Alzheimer's disease but early data indicate that it might be related to a decrease in the transmission of dopamine, a feel-good chemical in the brain. Ritalin, which is commonly used to treat attention deficit disorder, increases the transmission of dopamine in the brain.
A previous international clinical trial, funded by the National Institute on Aging, showed marked improvements on clinical testing for apathy among Alzheimer's patients who were given Ritalin compared to those who were not.
"Once you have depression, or apathy in this case, it makes it harder to focus on the environment," Grossberg said. "So by improving patients' energy levels, we think it will contribute to them being less likely to fall."
Falling and balance do not involve the hippocampus, which is most responsible for memory and most profoundly affected by the disease.
"But in the balance section of brain, there may be cells dying or chemical alterations that increase the risk for falls. It could be a combination of different things," Grossberg said.
"We do know that there are extremely high rates of apathy and that the risk of falls is much higher in Alzheimer's patients than in age-matched non-Alzheimer's patients," he said.
"It's very safe," Grossberg said. "We're using ultra-low doses in patch form. A lot of older people with Alzheimer's have trouble swallowing. Plus, with the patch you can have a gradual introduction to the blood stream and keep it level without peaks and valleys. So it's better tolerated."
When Nathe told Grossberg about her mother's behavior after being taken off the Ritalin, "he said, 'you know your mom's history. Let's go with what you're saying,'" Nathe said. "Within two days she was back to her normal self. And Grossberg adjusted other medications for her mood disorders, which helped.
"My mom is on 5 mg in the morning and 5 mg after lunch. That's not very much," Nathe said. "But it worked and it works now. I want her up and participating in as many things as she can. And that's what she does now."
Grossberg and his team are in the process of recruiting 40 St. Louis-area Alzheimer's patients at three nursing homes to participate in the four-week study. They hope to have data within a year.
"This is a high-risk population for falls, so they have to be watched round the clock to see if they tolerate the treatments and don't fall," Grossberg said. "Plus we need continuous observation to see what the results are."
(c)2013 St. Louis Post-Dispatch
Distributed by MCT Information Services
- Think herbal supplements are safe? Think again, book by SLU doctor says Mar 27, 2007 | not rated yet | 0
- Pediatric Ritalin may affect young brains Jul 18, 2007 | not rated yet | 0
- Adult ADHD linked with dopamine levels Aug 09, 2007 | not rated yet | 0
- Alleviating the fear of falling Jul 28, 2008 | not rated yet | 0
- Falls may be early sign of Alzheimer's Jul 18, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Change in momentum when a body is thrown up and falls back down.
5 hours ago Say, a body of mass 'm' is thrown at a certain angle with the vertical with certain initial velocity 'u'. The initial momentum of this object is mu....
change in speed and wavelength of light while travelling from one med
5 hours ago what is the mechanism by which light changes its speed and wavelength while travelling from one medium to other. I know it is c/n or lamda/n and know...
Calculus of Variation - Classical Mechanics
8 hours ago I'm reading Classical Mechanics (Taylor), and the 6th chapter is a basic introduction to calculus of variations. I'm super confused :confused: ...
Frictional Force Equation Doesn't Make Sense
8 hours ago Frictional Force is mathematically defined as: Ff = μ*m*g*cos(θ) , where μ is the coefficient of friction, m is the mass of the object, g is...
Calculating Steam Pressure in Closed Container
13 hours ago I am trying to calculate the volume of liquid water i need to place in a sealed container in order to obtain 10 psi of steam pressure in that closed...
Learning curve of Electromagnetism?
19 hours ago I'm taking a first year physics course and have been having a little trouble with the basics of newtons laws and forces and whatnot, though nothing...
- More from Physics Forums - Classical Physics
More news stories
(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...
Alzheimer's disease & dementia May 17, 2013 | 5 / 5 (2) | 0 |
(HealthDay)—Older individuals with nonmelanoma skin cancer (NMSC) seem to have a significantly reduced risk of developing Alzheimer's disease (AD), according to a study published online May 15 in Neurology.
Alzheimer's disease & dementia May 16, 2013 | 5 / 5 (1) | 0
People who have skin cancer may be less likely to develop Alzheimer's disease, according to new research published in the May 15, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. The li ...
Alzheimer's disease & dementia May 15, 2013 | 5 / 5 (1) | 0 |
(Medical Xpress)—Scientists at Washington University School of Medicine in St. Louis have helped identify many of the biomarkers for Alzheimer's disease that could potentially predict which patients will develop the disorder ...
Alzheimer's disease & dementia May 14, 2013 | 3 / 5 (1) | 0 |
A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment. The findings, ...
Alzheimer's disease & dementia May 13, 2013 | 4.2 / 5 (5) | 0 |
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
31 minutes ago | not rated yet | 0
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
8 hours ago | not rated yet | 0 |
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
8 hours ago | 4.5 / 5 (2) | 0 |
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
8 hours ago | not rated yet | 0
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
7 hours ago | not rated yet | 0
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
22 hours ago | not rated yet | 0 |